Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease

Chronic Respiratory Disease

Volumn 6, Issue 2, 2009, Pages 81-87

  Bolton, C E ^a   Stone, M D ^a   Edwards, P H ^b   Duckers, J M ^a   Evans, W D ^c   Shale, D J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Ely Bridge Surgery   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Ageing; Bone densitometry; COPD; Matrix proteins; Osteoporosis

Indexed keywords

CYTOKINE; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ARTICLE; BONE DENSITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIRCULATION; CONTROL GROUP; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; SPIROMETRY;

AGED; BIOLOGICAL MARKERS; BONE DENSITY; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION MEDIATORS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; OSTEOPOROSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; ROC CURVE; SEVERITY OF ILLNESS INDEX; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 65149092319     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972309103131     Document Type: Article

References (37)

1. Schols AMg., Broekhuizen Rg., Weling-Scheepers CAg., Wouters EFg.,. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005 ; 82: 53 - 59.
2. Bolton CEg., Ionescu AAg., Shiels KMg., Pettit RJg., Edwards PHg., Stone MDg.,. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004 ; 170: 1286 - 1293.
3. Sabit Rg., Bolton CEg., Edwards PHg., Pettit RJg., Evans WDg., McEniery CMg.,. Arterial stiffness and osteoporosis in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007 ; 175: 1259 - 1265.
4. Van Vliet Mg., Spruit MAg., Verleden Gg., Kasran Ag., Van Herck Eg., Pitta Fg.,. Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005 ; 172: 1105 - 1111.
5. Bolton CEg., Evans Mg., Ionescu AAg., Edwards SMg., Morris RHg., Dunseath Gg.,. Insulin resistance and inflammation - a further systemic complication of COPD. COPD 2007 ; 4: 121 - 126.
6. Kiel DPg., Zhang Yg., Hannan MTg., Anderson JJg., Baron JAg., Felson DTg.,. The effect of smoking at different life stages on bone mineral density in elderly men and women. Osteoporos Int 1996 ; 6: 240 - 248.
7. Nguyen TVg., Center JRg., Eisman JAg.,. Osteoporosis in elderly men and women: effects of dietary calcium, physical activity and body mass index. J Bone Miner Res 2000 ; 15: 322 - 331.
8. Manolagas SCg., Jilka RLg.,. Bone marrow, cytokines and bone remodelling. N Engl J Med 1995 ; 332: 305 - 311.
9. Melton LJg.,. Hip fractures: a worldwide problem today and tomorrow. Bone 1993 ; 14 (Suppl. 1): S1 - S8.
10. Canalis Eg.,. Clinical review 83: mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 1996 ; 81: 3441 - 3447.
11. Biskobing DMg.,. COPD and osteoporosis. Chest 2002 ; 121: 609 - 620. (Pubitemid 34133004)
12. Engelen MPg., Deutz NEg., Wouters EFg., Schols AMg.,. Enhanced levels of whole-body protein turnover in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000 ; 162: 1488 - 1492.
13. Funada Yg., Nishimura Yg., Yokoyama Mg.,. Imbalance of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 is associated with pulmonary emphysema in Klotho mice. Kobe J Med Sci 2004 ; 50: 59 - 67.
14. Churg Ag., Wang Rg., Wang Xg., Onnervik POg., Thim Kg., Wright JLg.,. Effect of an MMP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs. Thorax 2007 ; 62: 706 - 713.
15. Finlay GAg., OgDriscol LRg., Russell KJg., DgArcy EMg., Masterson JBg., FitzGerald MXg.,. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 1997 ; 156: 240 - 247.
16. Segura-Valdez Lg., Pardo Ag., Gaxiola Mg., Uhal BDg., Becerril Cg., Selman Mg.,. Upregulation of gelatinases A and B and collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000 ; 117: 684 - 694. (Pubitemid 30152206)
17. Imai Kg., Dalal SSg., Chen ESg., Downey Rg., Schulman LLg., Ginsburg Mg.,. Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema. Am J Respir Crit Care Med 2001 ; 163: 786 - 791.
18. Ito Ig., Nagai Sg., Handa Tg., Muro Sg., Hirai Tg., Tsukino Mg.,. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema. Am J Respir Crit Care Med 2005 ; 172: 1378 - 1382.
19. Demedts IKg., Morel-Montero Ag., Lebecque Sg., Pacheco Yg., Cataldo Dg., Joos GFg.,. Elevated MMP-12 protein levels in induced sputum from patients with COPD. Thorax 2006 ; 61: 196 - 201.
20. Elkington PTg., Friedland JSg.,. Matrix metalloproteinases in destructive pulmonary pathology. Thorax 2006 ; 61: 259 - 266.
21. Greenlee KJg., Werb Zg., Kheradmand Fg.,. Matrix metalloproteinases in lung: multiple, multifarious and multifaceted. Physiol Rev 2007 ; 87: 69 - 98.
22. Mao JTg., Tashkin DPg., Belloni PNg., Baileyhealy Ig., Baratelli Fg., Roth MDg.,. All-trans retinoic acid modulates the balance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with emphysema. Chest 2003 ; 124: 1724 - 1732.
23. Higashimoto Yg., Yamagata Yg., Iwata Tg., Okada Mg., Ishiguchi Tg., Sato Hg.,. Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients. Eur Respir J 2005 ; 25: 885 - 890.
24. Pinto-Plata Vg., Toso Jg., Lee Kg., Park Dg., Bilello Jg., Mullerova Hg.,. Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax 2007 ; 62: 595 - 601.
25. Lijnen HRg.,. Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost 2001 ; 86: 324 - 333.
26. Anderson TLg., del Carem Ovejero Mg., Kirkegaard Tg., Lenhard Tg., Foged NTg., Delaissf JMg.,. A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells. Bone 2004 ; 35: 1107 - 1119. (Pubitemid 39487357)
27. Vu THg., Shipley JMg., Bergers Gg., Berger JEg., Helms JAg., Hanahan Dg.,. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998 ; 93: 411 - 422.
28. Fabbri Lg., Pauwels RAg., Hurd SSg., ; GOLD Scientific Committee. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary updated 2003. COPD 2004 ; 1: 105 - 141.
29. WHO. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Geneva: WHO; 1994 (Technical Report Series 843).
30. Aldonyte Rg., Jansson Lg., Piitulainen Eg., Janciauskiene Sg.,. Circulating monocytes from healthy individuals and COPD patients. Respir Res 2003 ; 4: 11.
31. Yasmin, McEniery, CM, Wallace, S, Dakham, Z, Pulsalkar, P, Maki-Petaja, K. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25: 372-378.
32. Engsig MTg., Chen QJg., Vu THg., Pedersen ACg., Therkidsen Bg., Lund LRg.,. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 2000 ; 151: 879 - 889.
33. Teronen Og., Heikkil Pg., Konttinen YTg., Laitinen Mg., Salo Tg., Hanemaaijer Rg.,. MMP inhibition and downregulation by bisphosphonates. Ann N Y Acad Sci 1999 ; 878: 453 - 465. (Pubitemid 29353588)
34. Zhao Hg., Cai Gg., Du Jg., Xia Zg., Wang Lg., Zhu Tg.,. Expression of matrix metalloproteinase-9 mRNA in osteoporotic bone tissues. J Tongji Med Univ 1997 ; 17: 28 - 31.
35. Anker SDg., Clark ALg., Teixeira MMg., Hellewell PGg., Coats AJg.,. Loss of bone mineral in patients with cachexia due to chronic heart failure. Am J Cardiol 1999 ; 83: 612 - 615.
36. Elkin SLg., Fairney Ag., Burnett Sg., Kemp Mg., Kyd Pg., Burgess Jg.,. Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study. Osteoporos Int 2001 ; 12: 366 - 372.
37. Manolagas SCg.,. Role of cytokines in bone resorption. Bone 1995 ; 17 (Suppl): 63s - 67s.